Spindler, K. G., Pallisgaard, N., Andersen, R. F., & Jakobsen, A. (2014). Response to comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'. Br J Cancer.
Παραπομπή Chicago StyleSpindler, K-L G., N. Pallisgaard, R F. Andersen, και A. Jakobsen. "Response to Comment On ‘KRAS-mutated Plasma DNA As Predictor of Outcome From Irinotecan Monotherapy in Metastatic Colorectal Cancer'." Br J Cancer 2014.
Παραπομπή MLASpindler, K-L G., N. Pallisgaard, R F. Andersen, και A. Jakobsen. "Response to Comment On ‘KRAS-mutated Plasma DNA As Predictor of Outcome From Irinotecan Monotherapy in Metastatic Colorectal Cancer'." Br J Cancer 2014.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.